Conformational stability as a design target to control protein aggregation.

Non-native protein aggregation is a prevalent problem occurring in many biotechnological manufacturing processes and can compromise the biological activity of the target molecule or induce an undesired immune response. Additionally, some non-native aggregation mechanisms lead to amyloid fibril formation, which can be associated with debilitating diseases. For natively folded proteins, partial or complete unfolding is often required to populate aggregation-prone conformational states, and therefore one proposed strategy to mitigate aggregation is to increase the free energy for unfolding (ΔGunf) prior to aggregation. A computational design approach was tested using human γD crystallin (γD-crys) as a model multi-domain protein. Two mutational strategies were tested for their ability to reduce/increase aggregation rates by increasing/decreasing ΔGunf: stabilizing the less stable domain and stabilizing the domain-domain interface. The computational protein design algorithm, RosettaDesign, was implemented to identify point variants. The results showed that although the predicted free energies were only weakly correlated with the experimental ΔGunf values, increased/decreased aggregation rates for γD-crys correlated reasonably well with decreases/increases in experimental ΔGunf, illustrating improved conformational stability as a possible design target to mitigate aggregation. However, the results also illustrate that conformational stability is not the sole design factor controlling aggregation rates of natively folded proteins.

[1]  C. Dobson,et al.  Protein unfolding, amyloid fibril formation and configurational energy landscapes under high pressure conditions. , 2006, Chemical Society reviews.

[2]  Silvio C. E. Tosatto,et al.  The PASTA server for protein aggregation prediction. , 2007, Protein engineering, design & selection : PEDS.

[3]  Michele Vendruscolo,et al.  Prediction of aggregation-prone regions in structured proteins. , 2008, Journal of molecular biology.

[4]  B. Müller-Hill,et al.  Strengthening the dimerisation interface of Lac repressor increases its thermostability by 40 deg. C. , 2000, Journal of molecular biology.

[5]  O. Schueler‐Furman,et al.  Progress in Modeling of Protein Structures and Interactions , 2005, Science.

[6]  V. Eijsink,et al.  Rational engineering of enzyme stability. , 2004, Journal of biotechnology.

[7]  Paula Rahal,et al.  Molecular models of NS3 protease variants of the Hepatitis C virus , 2005, BMC Structural Biology.

[8]  J. King,et al.  Folding and stability of the isolated Greek key domains of the long‐lived human lens proteins γD‐crystallin and γS‐crystallin , 2007, Protein science : a publication of the Protein Society.

[9]  Roland L. Dunbrack,et al.  Bayesian statistical analysis of protein side‐chain rotamer preferences , 1997, Protein science : a publication of the Protein Society.

[10]  A. Robinson,et al.  Maximizing Recovery of Native Protein from Aggregates by Optimizing Pressure Treatment , 2008, Biotechnology progress.

[11]  Stephen J. Wright,et al.  Optimal design of thermally stable proteins , 2008, Bioinform..

[12]  S. Ray,et al.  Engineered disulfide bonds restore chaperone-like function of DJ-1 mutants linked to familial Parkinson's disease. , 2010, Biochemistry.

[13]  D. Baker,et al.  A large scale test of computational protein design: folding and stability of nine completely redesigned globular proteins. , 2003, Journal of molecular biology.

[14]  W. Gombotz,et al.  Minimization of recombinant human Flt3 ligand aggregation at the Tm plateau: a matter of thermal reversibility. , 1999, Biochemistry.

[15]  D. Foguel,et al.  Hydrostatic pressure rescues native protein from aggregates. , 1999, Biotechnology and bioengineering.

[16]  Xiaozhen Hu,et al.  Computer-based redesign of a beta sandwich protein suggests that extensive negative design is not required for de novo beta sheet design. , 2008, Structure.

[17]  J F Brandts,et al.  A simple model for proteins with interacting domains. Applications to scanning calorimetry data. , 1989, Biochemistry.

[18]  V. Eijsink,et al.  Directed evolution of enzyme stability. , 2005, Biomolecular engineering.

[19]  Michele Vendruscolo,et al.  Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. , 2005, Journal of molecular biology.

[20]  William F. Weiss,et al.  Computational design and biophysical characterization of aggregation-resistant point mutations for γD crystallin illustrate a balance of conformational stability and intrinsic aggregation propensity. , 2011, Biochemistry.

[21]  Jeffery G Saven,et al.  Computational protein design: Advances in the design and redesign of biomolecular nanostructures. , 2010, Current opinion in colloid & interface science.

[22]  J. King,et al.  Contributions of hydrophobic domain interface interactions to the folding and stability of human γD‐crystallin , 2005, Protein science : a publication of the Protein Society.

[23]  J. Carpenter,et al.  Partial molar volume, surface area, and hydration changes for equilibrium unfolding and formation of aggregation transition state: High-pressure and cosolute studies on recombinant human IFN-γ , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. King,et al.  Molecular basis of a progressive juvenile-onset hereditary cataract. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Wei Wang,et al.  Protein aggregation--pathways and influencing factors. , 2010, International journal of pharmaceutics.

[26]  John F. Carpenter,et al.  Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation , 2003, Pharmaceutical Research.

[27]  Pu Tian Computational protein design, from single domain soluble proteins to membrane proteins. , 2010, Chemical Society reviews.

[28]  Christopher J Roberts,et al.  Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies. , 2010, Journal of pharmaceutical sciences.

[29]  Christopher J Roberts,et al.  Non‐native protein aggregation kinetics , 2007, Biotechnology and bioengineering.

[30]  Geoffrey K. Hom,et al.  Full-sequence computational design and solution structure of a thermostable protein variant. , 2007, Journal of molecular biology.

[31]  C. Pace Determination and analysis of urea and guanidine hydrochloride denaturation curves. , 1986, Methods in enzymology.

[32]  María Vázquez-Rey,et al.  Aggregates in monoclonal antibody manufacturing processes , 2011, Biotechnology and bioengineering.

[33]  Christopher J Roberts,et al.  A Lumry-Eyring nucleated polymerization model of protein aggregation kinetics: 1. Aggregation with pre-equilibrated unfolding. , 2007, The journal of physical chemistry. B.

[34]  Huub Schellekens,et al.  Structure-Immunogenicity Relationships of Therapeutic Proteins , 2004, Pharmaceutical Research.

[35]  B. Kuhlman,et al.  Structure-based protocol for identifying mutations that enhance protein-protein binding affinities. , 2007, Journal of molecular biology.

[36]  Dusan Bratko,et al.  Protein aggregation in silico. , 2007, Trends in biotechnology.

[37]  M. James C. Crabbe,et al.  Protein Folds and Functional Similarity; the Greek Key/immunoglobulin Fold , 1995, Comput. Chem..

[38]  Melissa S Kosinski-Collins,et al.  Interdomain side‐chain interactions in human γD crystallin influencing folding and stability , 2005, Protein science : a publication of the Protein Society.

[39]  Regina M Murphy,et al.  Peptide aggregation in neurodegenerative disease. , 2002, Annual review of biomedical engineering.

[40]  Hanns-Christian Mahler,et al.  Protein aggregation: pathways, induction factors and analysis. , 2009, Journal of pharmaceutical sciences.

[41]  J. King,et al.  Formation of amyloid fibrils in vitro by human γD-crystallin and its isolated domains , 2008, Molecular vision.

[42]  Huub Schellekens,et al.  Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice , 2011, Pharmaceutical Research.

[43]  M. Karplus,et al.  Effective energy function for proteins in solution , 1999, Proteins.

[44]  R. Fernández-Lafuente Stabilization of multimeric enzymes: Strategies to prevent subunit dissociation , 2009 .

[45]  Francesc X. Avilés,et al.  AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides , 2007, BMC Bioinform..

[46]  David Baker,et al.  Macromolecular modeling with rosetta. , 2008, Annual review of biochemistry.

[47]  Wei Wang,et al.  Protein aggregation and its inhibition in biopharmaceutics. , 2005, International journal of pharmaceutics.

[48]  George I Makhatadze,et al.  Protein stability and surface electrostatics: a charged relationship. , 2006, Biochemistry.

[49]  Yi Lu,et al.  Design of functional metalloproteins , 2009, Nature.

[50]  V. Uversky,et al.  SS-Stabilizing Proteins Rationally: Intrinsic Disorder-Based Design of Stabilizing Disulphide Bridges in GFP , 2012, Journal of biomolecular structure & dynamics.

[51]  Eric A. Althoff,et al.  De Novo Computational Design of Retro-Aldol Enzymes , 2008, Science.

[52]  William F Weiss,et al.  Principles, approaches, and challenges for predicting protein aggregation rates and shelf life. , 2009, Journal of pharmaceutical sciences.

[53]  Amedeo Caflisch,et al.  Prediction of aggregation rate and aggregation‐prone segments in polypeptide sequences , 2005, Protein science : a publication of the Protein Society.

[54]  L. Serrano,et al.  Protein aggregation and amyloidosis: confusion of the kinds? , 2006, Current opinion in structural biology.

[55]  J. King,et al.  Probing folding and fluorescence quenching in human γD crystallin Greek key domains using triple tryptophan mutant proteins , 2004, Protein science : a publication of the Protein Society.

[56]  Thomas E. Creighton,et al.  Protein structure : a practical approach , 1997 .

[57]  BMC Bioinformatics , 2005 .

[58]  Robert H. Brown,et al.  An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis. , 2004, Biochemistry.

[59]  Andreas Plückthun,et al.  Consensus Design of Repeat Proteins , 2004, Chembiochem : a European journal of chemical biology.

[60]  Salvador Ventura,et al.  Prediction of "hot spots" of aggregation in disease-linked polypeptides , 2005, BMC Structural Biology.

[61]  Melissa S Kosinski-Collins,et al.  In vitro unfolding, refolding, and polymerization of human γD crystallin, a protein involved in cataract formation , 2003, Protein science : a publication of the Protein Society.

[62]  B. García-Moreno E.,et al.  Changes in stability upon charge reversal and neutralization substitution in staphylococcal nuclease are dominated by favorable electrostatic effects. , 2003, Biochemistry.

[63]  Anne S De Groot,et al.  Immunogenicity of protein therapeutics. , 2007, Trends in immunology.

[64]  Yi Liu,et al.  RosettaDesign server for protein design , 2006, Nucleic Acids Res..

[65]  A. Plückthun,et al.  Different equilibrium stability behavior of ScFv fragments: identification, classification, and improvement by protein engineering. , 1999, Biochemistry.

[66]  J. Kelly,et al.  R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression , 2006, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[67]  Amedeo Caflisch,et al.  Computational models for the prediction of polypeptide aggregation propensity. , 2006, Current opinion in chemical biology.

[68]  A. Plückthun,et al.  New protein engineering approaches to multivalent and bispecific antibody fragments. , 1997, Immunotechnology : an international journal of immunological engineering.

[69]  Fred Jacobson,et al.  Protein aggregation and bioprocessing , 2006, The AAPS Journal.

[70]  M. Lehmann,et al.  Engineering proteins for thermostability: the use of sequence alignments versus rational design and directed evolution. , 2001, Current opinion in biotechnology.

[71]  L. Serrano,et al.  Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.

[72]  김삼묘,et al.  “Bioinformatics” 특집을 내면서 , 2000 .

[73]  Tim J Kamerzell,et al.  Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development. , 2011, Advanced drug delivery reviews.

[74]  A. Fink Protein aggregation: folding aggregates, inclusion bodies and amyloid. , 1998, Folding & design.

[75]  Brian Kuhlman,et al.  Structure-based design of supercharged, highly thermoresistant antibodies. , 2012, Chemistry & biology.

[76]  R. Wetzel,et al.  Breakdown in the relationship between thermal and thermodynamic stability in an interleukin-1 beta point mutant modified in a surface loop. , 1993, Protein engineering.

[77]  D. Kalonia,et al.  Temperature- and pH-Induced Multiple Partially Unfolded States of Recombinant Human Interferon-α2a: Possible Implications in Protein Stability , 2003, Pharmaceutical Research.

[78]  J Pierard,et al.  Amyloid , 2023, Arthritis and rheumatism.

[79]  T. Arakawa,et al.  Effect of additives on protein aggregation. , 2009, Current pharmaceutical biotechnology.

[80]  R. Wetzel Mutations and off-pathway aggregation of proteins. , 1994, Trends in biotechnology.

[81]  A. Plückthun,et al.  Stability engineering of antibody single-chain Fv fragments. , 2001, Journal of molecular biology.

[82]  Babatunde A. Ogunnaike,et al.  Multi-variate approach to global protein aggregation behavior and kinetics: effects of pH, NaCl, and temperature for alpha-chymotrypsinogen A. , 2010, Journal of pharmaceutical sciences.

[83]  C. Pace,et al.  Substrate stabilization of lysozyme to thermal and guanidine hydrochloride denaturation. , 1980, Journal of Biological Chemistry.

[84]  D. Baker,et al.  An orientation-dependent hydrogen bonding potential improves prediction of specificity and structure for proteins and protein-protein complexes. , 2003, Journal of molecular biology.

[85]  Igor N. Berezovsky,et al.  Entropic Stabilization of Proteins and Its Proteomic Consequences , 2005, PLoS Comput. Biol..

[86]  Angela M. Gronenborn,et al.  The Structure of the Cataract-Causing P23T Mutant of Human γD-Crystallin Exhibits Distinctive Local Conformational and Dynamic Changes†,‡ , 2009, Biochemistry.

[87]  J. King,et al.  Glutamine Deamidation Destabilizes Human γD-Crystallin and Lowers the Kinetic Barrier to Unfolding* , 2006, Journal of Biological Chemistry.

[88]  George I Makhatadze,et al.  Contribution of surface salt bridges to protein stability: guidelines for protein engineering. , 2003, Journal of molecular biology.

[89]  G Vriend,et al.  Structural and mutagenesis studies of leishmania triosephosphate isomerase: a point mutation can convert a mesophilic enzyme into a superstable enzyme without losing catalytic power. , 1999, Protein engineering.

[90]  R. Rosenfeld Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[91]  A. Plückthun,et al.  Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability. , 1998, Biochemistry.

[92]  Dusan Bratko,et al.  Molecular simulation of protein aggregation , 2007, Biotechnology and bioengineering.

[93]  M. Goldberg,et al.  The renaturation of reduced chymotrypsinogen A in guanidine HCl. Refolding versus aggregation. , 1978, The Journal of biological chemistry.

[94]  Vladimir I Razinkov,et al.  Native-state solubility and transfer free energy as predictive tools for selecting excipients to include in protein formulation development studies. , 2012, Journal of pharmaceutical sciences.

[95]  F. Young Biochemistry , 1955, The Indian Medical Gazette.